The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Experimental Peptide Creates Risk for Athletes Research Peptides In Minnesota: Why Not For Human Consumption Doesn't Protect You Holt Law